Xu XH - Search Results

1

Recombinant human adenovirus-p53 therapy for the treatment of nasopharyngeal carcinoma: a meta-analysis.

Yuan C, Xu XH, Chen Z. Yuan C, et al. Among authors: xu xh. Springerplus. 2016 Oct 27;5(1):1885. doi: 10.1186/s40064-016-3574-6. eCollection 2016. Springerplus. 2016. PMID: 27843742 Free PMC article. Review.

2

Combining antiangiogenic therapy and radiation in nasopharyngeal carcinoma.

Chen Z, Xu XH. Chen Z, et al. Among authors: xu xh. Saudi Med J. 2015 Jun;36(6):659-64. doi: 10.15537/smj.2015.6.11460. Saudi Med J. 2015. PMID: 25987106 Free PMC article. Review.

3

Combination treatment with antiEGFR monoclonal antibodies in advanced nasopharyngeal carcinoma : a meta-analysis.

Yuan C, Xu XH, Chen Z. Yuan C, et al. Among authors: xu xh. J BUON. 2015 Nov-Dec;20(6):1510-7. J BUON. 2015. PMID: 26854448 Free article.

4

Roles of nucleolin. Focus on cancer and anti-cancer therapy.

Chen Z, Xu X. Chen Z, et al. Saudi Med J. 2016 Dec;37(12):1312-1318. doi: 10.15537/smj.2016.12.15972. Saudi Med J. 2016. PMID: 27874146 Free PMC article. Review.

5

Relationship between serum uric acid and metastatic and nonmetastatic rectal cancer patients with undergoing no chemotherapy.

Yuan C, Xu XH, Wang XL, Xu L, Chen Z, Li YQ. Yuan C, et al. Among authors: xu l, xu xh. Medicine (Baltimore). 2016 Nov;95(47):e5463. doi: 10.1097/MD.0000000000005463. Medicine (Baltimore). 2016. PMID: 27893692 Free PMC article.

6

Low expression of nm23-H1 associates with poor survival of nasopharyngeal carcinoma patients: A prisma-compliant meta-analysis.

Yuan C, Xu XH, Xu L, Sun M, Ni LH, Liu Y, Ran F, Wang XL, Chen Z, Zhang K, Zeng G. Yuan C, et al. Among authors: xu l, xu xh. Medicine (Baltimore). 2017 Jun;96(24):e7153. doi: 10.1097/MD.0000000000007153. Medicine (Baltimore). 2017. PMID: 28614246 Free PMC article. Review.

7

No association of TNF-α-308G/A polymorphisms with head and neck cancer risk: A PRISMA-compliant meta-analysis.

Yuan C, Xu XH, Xu L, Liu Y, Sun M, Ni LH, Wang XL, Chen Z, Zhang K, Zeng G. Yuan C, et al. Among authors: xu l, xu xh. Medicine (Baltimore). 2017 Jun;96(25):e7298. doi: 10.1097/MD.0000000000007298. Medicine (Baltimore). 2017. PMID: 28640146 Free PMC article. Review.

8

Cetuximab versus nimotuzumab for the treatment of advanced nasopharyngeal carcinoma: A network meta-analysis.

Yuan C, Xu XH, Xu L, Liu Y, Sun M, Ni LH, Wang XL, Chen Z, Zhang K, Wan HL, Zeng G. Yuan C, et al. Among authors: xu l, xu xh. J BUON. 2017 Jul-Aug;22(4):1004-1010. J BUON. 2017. PMID: 28952220 Free article.

9

The clinical value of detecting circulating tumour cells in the peripheral blood of nasopharyngeal carcinoma patients.

Chen Z, Xu L, Xu X, Yuan C. Chen Z, et al. Oncol Lett. 2018 May;15(5):6283-6290. doi: 10.3892/ol.2018.8155. Epub 2018 Mar 2. Oncol Lett. 2018. PMID: 29731846 Free PMC article.

10

Which neoadjuvant chemotherapy regimen should be recommended for patients with advanced nasopharyngeal carcinoma?: A network meta-analysis.

Yuan C, Xu XH, Luo SW, Wang L, Sun M, Ni LH, Xu L, Wang XL, Zeng G. Yuan C, et al. Among authors: xu l, xu xh. Medicine (Baltimore). 2018 Aug;97(34):e11978. doi: 10.1097/MD.0000000000011978. Medicine (Baltimore). 2018. PMID: 30142830 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

990 results

Search Page

Filters